Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

HKG:2637 Statistics

Total Valuation

HKG:2637 has a market cap or net worth of HKD 13.91 billion. The enterprise value is 12.55 billion.

Market Cap	13.91B
Enterprise Value	12.55B

Important Dates

The last earnings date was Monday, March 30, 2026.

Earnings Date	Mar 30, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2637 has 78.71 million shares outstanding.

Current Share Class	78.71M
Shares Outstanding	78.71M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	28.80%
Owned by Institutions (%)	6.04%
Float	14.27M

Valuation Ratios

The trailing PE ratio is 62.27.

PE Ratio	62.27
Forward PE	n/a
PS Ratio	21.46
PB Ratio	7.84
P/TBV Ratio	7.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	63.70
EV / Sales	19.37
EV / EBITDA	57.78
EV / EBIT	58.66
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.31, with a Debt / Equity ratio of 0.07.

Current Ratio	6.31
Quick Ratio	6.06
Debt / Equity	0.07
Debt / EBITDA	0.56
Debt / FCF	n/a
Interest Coverage	33.52

Financial Efficiency

Return on equity (ROE) is 16.58% and return on invested capital (ROIC) is 49.21%.

Return on Equity (ROE)	16.58%
Return on Assets (ROA)	9.23%
Return on Invested Capital (ROIC)	49.21%
Return on Capital Employed (ROCE)	11.88%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	3.95M
Profits Per Employee	1.20M
Employee Count	164
Asset Turnover	0.45
Inventory Turnover	2.12

Taxes

In the past 12 months, HKG:2637 has paid 23.42 million in taxes.

Income Tax	23.42M
Effective Tax Rate	10.63%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	143.72
200-Day Moving Average	n/a
Relative Strength Index (RSI)	68.86
Average Volume (20 Days)	372,113

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2637 had revenue of HKD 648.05 million and earned 197.00 million in profits. Earnings per share was 2.84.

Revenue	648.05M
Gross Profit	540.33M
Operating Income	213.95M
Pretax Income	220.42M
Net Income	197.00M
EBITDA	217.21M
EBIT	213.95M
Earnings Per Share (EPS)	2.84

Balance Sheet

The company has 1.48 billion in cash and 122.57 million in debt, with a net cash position of 1.36 billion or 17.25 per share.

Cash & Cash Equivalents	1.48B
Total Debt	122.57M
Net Cash	1.36B
Net Cash Per Share	17.25
Equity (Book Value)	1.77B
Book Value Per Share	n/a
Working Capital	1.35B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	3.33M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 83.38%, with operating and profit margins of 33.01% and 30.40%.

Gross Margin	83.38%
Operating Margin	33.01%
Pretax Margin	34.01%
Profit Margin	30.40%
EBITDA Margin	33.52%
EBIT Margin	33.01%
FCF Margin	n/a

Dividends & Yields

HKG:2637 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	1.42%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2